Laboratory Total Stockholder Equity from 2010 to 2025

LH Stock  USD 230.15  3.19  1.37%   
Laboratory's Total Stockholder Equity is increasing with slightly volatile movements from year to year. Total Stockholder Equity is estimated to finish at about 8.5 B this year. Total Stockholder Equity is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. View All Fundamentals
 
Total Stockholder Equity  
First Reported
1989-03-31
Previous Quarter
8.2 B
Current Value
8.1 B
Quarterly Volatility
3.1 B
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 218.7 M, Total Revenue of 13.7 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.012 or PTB Ratio of 3.26. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Check out the analysis of Laboratory Correlation against competitors.

Latest Laboratory's Total Stockholder Equity Growth Pattern

Below is the plot of the Total Stockholder Equity of Laboratory of over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Laboratory's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Total Stockholder Equity10 Years Trend
Slightly volatile
   Total Stockholder Equity   
       Timeline  

Laboratory Total Stockholder Equity Regression Statistics

Arithmetic Mean6,051,713,125
Geometric Mean4,804,656,530
Coefficient Of Variation51.04
Mean Deviation2,626,773,984
Median6,971,400,000
Standard Deviation3,088,994,324
Sample Variance9541885.9T
Range9.9B
R-Value0.91
Mean Square Error1830750.4T
R-Squared0.82
Slope587,861,985
Total Sum of Squares143128289T

Laboratory Total Stockholder Equity History

20258.5 B
20248.1 B
20237.9 B
202210.1 B
202110.3 B
20209.4 B
20197.6 B

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Stockholder Equity8.1 B8.5 B

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
8.85
Revenue Per Share
155.052
Quarterly Revenue Growth
0.098
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.